Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2012-01-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All variables will be collected from a cohort of PXE monitored in our PXE Health and Care centre at the university hospital of Angers. Quantification of the arterial wall calcium load will be performed using helicoidal CT-scan. These variables will be compared to the same measurements performed in type 2 diabetic and chronic kidney disease patients paired by age and gender.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pseudoxanthoma Elasticum
Patients with genetically and clincally proven PXE
No interventions assigned to this group
chronic kidney disease
Type 2 diabetic patients with mediacalcosis and matched to PXE patients for gender and age (+/- 5 yrs).
No interventions assigned to this group
Diabetes
patients with chronic kidney disease and matched to PXE patients for gender and age (+/- 5 yrs).
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Type 2 diabetic patients with mediacalcosis (i.e. Ankle Brachial Index \> 1.30)
* Patients with a chronic kidney disease (CKD), before kidney transplantation
* All patients should be affiliated to a Health care system
Exclusion Criteria
* Patient under the age of 18 yrs
* Patient unwilling to participate to the study
* Pregnant women
* Patient not affiliated to a Health care system
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Angers
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yannick LE CORRE, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Dermatology, University Hospital of Angers, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital
Angers, Pays de la Loire Region, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ludovic MARTIN, MD, PhD
Role: primary
Georges LEFTHERIOTIS, MD, PhD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AOI-2011
Identifier Type: -
Identifier Source: org_study_id